REVB Q1 2021 Earnings — Revelation Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

REVBRevelation Biosciences, Inc.

$2M

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$9,972

Operating Income

-$3M

Net Income

-$3M

EPS (Diluted)

$-6977.04

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$102,325

Balance Sheet

Total Assets

$74M

Total Liabilities

$5M

Stockholders' Equity

$69M

Cash & Equivalents

$74M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$9,972	$0	—
Operating Income	-$3M	-$7,160	-36320.5%
Net Income	-$3M	-$7,160	-36385.4%